DE3581993D1 - Verfahren zur herstellung einer keuchhusten-impfstoffkomponente und kombinierter impfstoff,bestehend aus keuchhustenantigen diphterietoxoid und tetanustoxoid. - Google Patents

Verfahren zur herstellung einer keuchhusten-impfstoffkomponente und kombinierter impfstoff,bestehend aus keuchhustenantigen diphterietoxoid und tetanustoxoid.

Info

Publication number
DE3581993D1
DE3581993D1 DE8585106303T DE3581993T DE3581993D1 DE 3581993 D1 DE3581993 D1 DE 3581993D1 DE 8585106303 T DE8585106303 T DE 8585106303T DE 3581993 T DE3581993 T DE 3581993T DE 3581993 D1 DE3581993 D1 DE 3581993D1
Authority
DE
Germany
Prior art keywords
pertussis
vaccine
diphtheria
tetanoxoxide
antigenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585106303T
Other languages
English (en)
Inventor
Akihiro Ginnaga
Mitsuo Sakoh
Hisashi Kitagawa
Shin Sakuma
Hiroshi Koba
Tsukasa Nishihara
Sadahiro Hirashima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Application granted granted Critical
Publication of DE3581993D1 publication Critical patent/DE3581993D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE8585106303T 1984-09-22 1985-05-22 Verfahren zur herstellung einer keuchhusten-impfstoffkomponente und kombinierter impfstoff,bestehend aus keuchhustenantigen diphterietoxoid und tetanustoxoid. Expired - Lifetime DE3581993D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59198899A JPS6176422A (ja) 1984-09-22 1984-09-22 百日ぜきコンポ−ネントワクチンおよび百日ぜき・ジフテリア・破傷風混合ワクチンの製造方法

Publications (1)

Publication Number Publication Date
DE3581993D1 true DE3581993D1 (de) 1991-04-11

Family

ID=16398788

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585106303T Expired - Lifetime DE3581993D1 (de) 1984-09-22 1985-05-22 Verfahren zur herstellung einer keuchhusten-impfstoffkomponente und kombinierter impfstoff,bestehend aus keuchhustenantigen diphterietoxoid und tetanustoxoid.

Country Status (7)

Country Link
EP (1) EP0175841B1 (de)
JP (1) JPS6176422A (de)
KR (1) KR920009730B1 (de)
AT (1) ATE61230T1 (de)
AU (1) AU568743B2 (de)
CA (1) CA1239345A (de)
DE (1) DE3581993D1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4563303A (en) * 1984-04-14 1986-01-07 Judicial Foundation The Chemosero-Therapeutic Research Institute Method for purification of filamentous hemagglutinin
FR2597605B1 (fr) * 1986-04-16 1989-06-23 Merieux Inst Nouveau materiau pour chromatographie d'affinite et son application a la separation et a la purification des antigenes proteiques des bacteries du genre bordetella
EP0267998A1 (de) * 1986-11-17 1988-05-25 Institut Pasteur Mittel zur Unterstützung gegen Infektion und Vergiftung von Bordetella
CA1337859C (en) * 1987-04-24 1996-01-02 Masashi Chazono Method for culturing bordetella pertussis, a pertussis toxoid and a pertussis vaccine
US5139776A (en) * 1987-04-24 1992-08-18 The Research Foundation For Microbial Diseases Of Osaka University Method for culturing Bordetella pertussis, a pertussis toxoid and a pertussis vaccine
GB8807860D0 (en) * 1988-04-05 1988-05-05 Connaught Lab Pertussis vaccine
JP2849632B2 (ja) * 1988-04-08 1999-01-20 社団法人北里研究所 ワクチン製剤
CA1341123C (en) * 1988-10-27 2000-10-17 David A. Relman Filamentous hemagglutinin of b. pertussis
GB8910570D0 (en) * 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
IT1248735B (it) * 1990-06-21 1995-01-26 Sclavo Spa Vaccini acellulari contro la pertosse
IL98715A0 (en) * 1990-08-13 1992-07-15 American Cyanamid Co Filamentous hemaglutinin of bodetella pertussis as a carrier molecule for conjugate vaccines
JP3884066B2 (ja) * 1994-06-10 2007-02-21 財団法人化学及血清療法研究所 ボルデテラ属菌産生壊死毒素の精製方法およびトキソイド

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4247452A (en) * 1978-03-01 1981-01-27 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Purification of pertussis haemagglutinins
US4500639A (en) * 1981-10-15 1985-02-19 Teijin Limited Culturing Bordetella in media containing etherified cyclodextrin
US4515714A (en) * 1983-03-09 1985-05-07 Juridicial Foundation, The Chemo-Semo-Sero-Therapeutic Research Institute Method for purification of hepatitis B virus surface antigen
CA1213234A (en) * 1983-03-30 1986-10-28 Akihiro Ginnaga Method for the production of ha fraction containing protective antigens of bordetella pertussis and pertussis vaccine
JPS6098988A (ja) * 1983-11-01 1985-06-01 Chemo Sero Therapeut Res Inst Ｌｐｆ−ｈａの精製法
US4563303A (en) * 1984-04-14 1986-01-07 Judicial Foundation The Chemosero-Therapeutic Research Institute Method for purification of filamentous hemagglutinin
KR890001003B1 (ko) * 1984-07-19 1989-04-18 자이단 호오진 까가꾸 오요비 겟세이 료오호 겐뀨쇼 Lpf-ha의 정제방법

Also Published As

Publication number Publication date
CA1239345A (en) 1988-07-19
ATE61230T1 (de) 1991-03-15
EP0175841A2 (de) 1986-04-02
KR860002570A (ko) 1986-04-26
KR920009730B1 (ko) 1992-10-22
JPS6176422A (ja) 1986-04-18
AU4245985A (en) 1986-03-27
AU568743B2 (en) 1988-01-07
JPH0574576B2 (de) 1993-10-18
EP0175841B1 (de) 1991-03-06
EP0175841A3 (en) 1987-08-19

Similar Documents

Publication Publication Date Title
DE3581993D1 (de) Verfahren zur herstellung einer keuchhusten-impfstoffkomponente und kombinierter impfstoff,bestehend aus keuchhustenantigen diphterietoxoid und tetanustoxoid.
DE69116781D1 (de) Integriertes Verfahren zur Herstellung von Kohlenoxyd
ATE87003T1 (de) Oligosaccharide, immunogene und impstoffe und verfahren zur herstellung dieser oligosaccharide, immunogene und impstoffe.
DE3761877D1 (de) Auf phosphorsaeureester basierende, oberflaechenaktive zusammensetzungen, deren herstellungsverfahren und deren verwendung um wirksame praeparate herzustellen.
DE3771650D1 (de) Verfahren zur herstellung von hochreinem 4,6-diamino-1,3-benzoldiol.
DE3883408D1 (de) Verfahren zur Herstellung von Avermectinen und die verwendeten Kulturen.
ATE116541T1 (de) Verfahren zur herstellung mikronisierter bioabbaubarer partikel.
DE69329500T2 (de) Ein verfahren zur herstellung von immunosuppressiva und eine neuartige mikrobielle spezies, die dabei eingesetzt wird
DE3751478D1 (de) Herstellungsverfahren einer viskositätsstabilen antisäurezusammensetzung.
DE3684434D1 (de) Verfahren zur herstellung von 2-keto-d-glukarsaeure.
DE69427955T2 (de) Verfahren zur Herstellung von 2,2-Difluorketensilylacetalen und alpha,alpha-Difluor-beta -Silyloxy-1,3-Dioxolan-4-Propansäureestern
ATE87486T1 (de) Verfahren zur herstellung von toxoid.
HUT45564A (en) Process for producing hirudine variants
DE59209053D1 (de) Verfahren zur Herstellung aktivierter Sialinsäuren
DE69033833D1 (de) Verfahren zur Herstellung von Butantetracarbonsäure
DE59010812D1 (de) Verfahren zur Herstellung von 2-Acylamino-6-halogen-purin aus 2,9-Diacylguanin
DE69321767D1 (de) Verfahren zur Herstellung von N-Alkyl oder N-Cycloalkyl-2-Benzolthiazolesulfenimiden
ATE43342T1 (de) Verfahren zur herstellung von hydrogeno- oder halogenosilanen.
DE69015499D1 (de) Verfahren zur Herstellung von Castanosperminestern.
DE68903610D1 (de) Verfahren zur herstellung von fluorverbindungen sowie dadurch herstellbare produkte.
GR3001086T3 (en) Substituted dioxanones, method for preparing same and use thereof
DE59008852D1 (de) Verfahren zur Herstellung von 2-Acylamino-9-acyl-6-halogen-purinen.
ATE41929T1 (de) Verfahren zur herstellung von thiotetronsaeure.
DE3577314D1 (de) Verfahren zur herstellung von 2-beta-d-ribofuranosylselenazol-4-carboxamid.
DE69228761D1 (de) Verfahren zur herstellung von neuraminidase

Legal Events

Date Code Title Description
8364 No opposition during term of opposition